RADIATION · Unmapped registry intervention
Stereotactic Body Radiotherapy
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
NCT03693014
Study summary
ClinicalTrials.govA Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Melanoma Cancerunresolved
Lung Cancerverified · MONDO: lung cancer
Bladder Cancerunresolved
Renal Cancerunresolved
Head/Neck Cancersunresolved
Interventions
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Mapped research locations
New YorkNew York, United States1HartfordConnecticut, United States1AllentownPennsylvania, United States1CommackNew York, United States1Basking RidgeNew Jersey, United States1HarrisonNew York, United States1MiddletownNew Jersey, United States1MontvaleNew Jersey, United States1UniondaleNew York, United States1Rockville CentreNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03693014 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.